Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, OMV, Strabag (18/11/2019)

24.11.2019

Valneva: Valneva SE, a french/Austrian biotech company developing and commercializing vaccines for infectious diseases with major unmet medical needs, today announced excellent final Phase 1 results for its single-shot chikungunya vaccine candidate, VLA1553. The objectives of the Phase 1 study (VLA1553-101) were to assess the safety and immunogenicity profile of VLA1553 after a single vaccination across three dose levels. Today´s final analysis of the study includes the safety and immunogenicity results up to Month 13 and full results from the “intrinsic human viral challenge.” The safety profile observed in the prior analysis, announced in May 20191, was confirmed. VLA1553 was generally safe in all dose groups. The low and medium dose groups were well tolerated and showed a superior safety profile, including viremia, compared to the high dose group. No adverse events of special interest (e.g. chikungunya infection related) and no vaccine related Serious Adverse Events (SAEs) were reported up to Month 13. The product candidate´s local tolerability profile was excellent.
Valneva: weekly performance: -4.37%

OMV: OMV, the international integrated oil and gas company headquartered in Vienna, has agreed to sell its 69% interest in the Maari Field, located in New Zealand’s offshore Taranaki Basin, to Jadestone Energy Inc., an independent oil and gas company focused on the Asia Pacific region. The agreed purchase price is USD 50 mn, subject to closing adjustments. The effective date of the transaction is January 1, 2019 and the closing of the transaction is subject to Joint Venture and New Zealand Government approvals. Average production of the divested assets in 2018 was around 5 kboe/d (net to OMV). “The divestment of the Maari Field further optimizes our portfolio and will shift us in New Zealand to a gas-only producer. This underlines OMV’s strategy to produce significantly more natural gas than oil to reduce the carbon intensity of the product portfolio in the future”, said Johann Pleininger, OMV Board Member Upstream and Deputy Chairman of the Executive Board.
OMV: weekly performance: -1.04%

Strabag: The Canadian subsidiary of the Strabag Group has been awarded the Ashbridges Bay Treatment Plant Integrated Pumping Station – Construction Contract 2 by the City of Toronto to build deep concrete shafts and chambers and feeder tunnels for the new Integrated Pumping Station at Ashbridges Bay Treatment Plant at a cost of almost CAD 120 mn, the equivalent of about Euro 80 mn. “The pumping station is part of a larger infrastructure programme aimed at increasing wastewater capacity in the event of heavy rain and so improve the water quality of Toronto’s waterways and Lake Ontario,” explains project manager Simon Köck.
Strabag: weekly performance: 1.29%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/11/2019)


Partners









latest 21st Austria

21st Austria weekly - Valneva, OMV, Strabag (18/11/2019)


24.11.2019


Valneva: Valneva SE, a french/Austrian biotech company developing and commercializing vaccines for infectious diseases with major unmet medical needs, today announced excellent final Phase 1 results for its single-shot chikungunya vaccine candidate, VLA1553. The objectives of the Phase 1 study (VLA1553-101) were to assess the safety and immunogenicity profile of VLA1553 after a single vaccination across three dose levels. Today´s final analysis of the study includes the safety and immunogenicity results up to Month 13 and full results from the “intrinsic human viral challenge.” The safety profile observed in the prior analysis, announced in May 20191, was confirmed. VLA1553 was generally safe in all dose groups. The low and medium dose groups were well tolerated and showed a superior safety profile, including viremia, compared to the high dose group. No adverse events of special interest (e.g. chikungunya infection related) and no vaccine related Serious Adverse Events (SAEs) were reported up to Month 13. The product candidate´s local tolerability profile was excellent.
Valneva: weekly performance: -4.37%

OMV: OMV, the international integrated oil and gas company headquartered in Vienna, has agreed to sell its 69% interest in the Maari Field, located in New Zealand’s offshore Taranaki Basin, to Jadestone Energy Inc., an independent oil and gas company focused on the Asia Pacific region. The agreed purchase price is USD 50 mn, subject to closing adjustments. The effective date of the transaction is January 1, 2019 and the closing of the transaction is subject to Joint Venture and New Zealand Government approvals. Average production of the divested assets in 2018 was around 5 kboe/d (net to OMV). “The divestment of the Maari Field further optimizes our portfolio and will shift us in New Zealand to a gas-only producer. This underlines OMV’s strategy to produce significantly more natural gas than oil to reduce the carbon intensity of the product portfolio in the future”, said Johann Pleininger, OMV Board Member Upstream and Deputy Chairman of the Executive Board.
OMV: weekly performance: -1.04%

Strabag: The Canadian subsidiary of the Strabag Group has been awarded the Ashbridges Bay Treatment Plant Integrated Pumping Station – Construction Contract 2 by the City of Toronto to build deep concrete shafts and chambers and feeder tunnels for the new Integrated Pumping Station at Ashbridges Bay Treatment Plant at a cost of almost CAD 120 mn, the equivalent of about Euro 80 mn. “The pumping station is part of a larger infrastructure programme aimed at increasing wastewater capacity in the event of heavy rain and so improve the water quality of Toronto’s waterways and Lake Ontario,” explains project manager Simon Köck.
Strabag: weekly performance: 1.29%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/11/2019)




 

Bildnachweis

Aktien auf dem Radar: UBM , Palfinger , Warimpex , Lenzing , Addiko Bank , Frequentis , Uniqa , Erste Group , Wienerberger , ATX , Andritz , CA Immo , Immofinanz , ATX Prime , Österreichische Post , RBI , Polytec , Rosenbauer , Zumtobel , FACC , Pierer Mobility AG , DO&CO , Josef Manner & Comp. AG , Mayr-Melnhof , OMV , Österreichische Staatsdruckerei Holding , S Immo , UIAG , EVN , Strabag , Flughafen Wien.


Random Partner

Frequentis
Frequentis mit Firmensitz in Wien ist ein internationaler Anbieter von Kommunikations- und Informationssystemen für Kontrollzentralen mit sicherheitskritischen Aufgaben. Solche „Control Center Solutions" entwickelt und vertreibt Frequentis in den Segmenten Air Traffic Management (zivile und militärische Flugsicherung, Luftverteidigung) und Public Safety & Transport (Polizei, Feuerwehr, Rettungsdienste, Schifffahrt, Bahn).

>> Besuchen Sie 51 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten